List View

Displaying 2,901 - 2,925 of 2,995

Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer

Immunotherapy for Breast Cancer

Cancer Interception and Screening with Liquid Biopsy

Minimal Residual Disease (MRD): Tissue-agnostic or Tumor-informed?

NGS Molecular Testing in Blood vs Tissue? How About in Other Biospecimens?

Liquid Biopsies in Genitourinary Cancers

Biomarkers in Renal Cell Cancer

Radiation Therapy for Renal Cell Carcinoma

Dual Immunotherapy

Immunotherapy Plus TKI

Theragnostics & Novel Imaging in Renal Cell Carcinoma

PARP Inhibitors in Earlier Stages of Prostate Cancer- Current Data & Future Directions.pdf

Education and Clinical Trials to Address Lack of Diversity, Equality and Inclusion (DEI) in Cancer

Prostate Cancer Disparities

Racial Inequity and Other Social Disparities in the Diagnosis and Management of Bladder Cancer

Molecular Imaging in RCC

HIF2alpha Inhibitors RCC

Non-Clear Cell Updates in RCC

CAR-T Cell in RCC

Pathology Classification of Bladder Cancer

Novel Biomarkers in Urothelial Carcinoma

Peri-Operative Therapies

Novel Immunotherapies

Novel ADCs (Beyond anti-HER2)

The Impact of Variant Histology in Urothelial Carcinoma